Cost-utility analysis of cinacalcet in addition to standard of care in the UK.
Ray
Joshua A
JA
Valentine
William J
WJ
Palmer
Andrew J
AJ
D000069449:Cinacalcet; D003362:Cost-Benefit Analysis; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000191:economics* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000188:drug therapy; D009281:Naphthalenes / Q000191:economics* / Q000627:therapeutic use*; D010281:Parathyroid Hormone / Q000097:blood; D006113:United Kingdom